Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Who Says Football Doesn't Do Fairytales?
Once upon a time, on 21 April 2014, something extraordinary happened, as unfashionable Burnley sealed their promotion to the Premier League. It was the improbable culmination to one of the most magical, inspirational and unpredictable stories in the modern game. This is English football's Moneyball. At the start of the season, the Lancashire club were among the favourites for relegation from the Championship, with a tiny budget, threadbare squad and a manager plucked from the supposed scrapheap. Few outside of Turf Moor gave them a hope: Burnley were there to make up the numbers alongside big-budget, high-spending rivals. Even before they sold their star striker in the opening month of the campaign... Who Says Football Doesn't Do Fairytales? tells the story of a season which Dyche called a 'marker for history' and gives an insight into how a sporting David can still overcome economic strictures to beat the Goliaths.
Against All Odds
None
5000-1: The Leicester City Story
THE INCREDIBLE AS-IT-HAPPENED STORY OF LEICESTER CITY’S MARCH TO PREMIER LEAGUE VICTORY In August 2015 bookmakers priced Leicester at 5000-1 to win the Premier League – the same odds as Elvis being found alive. On 2 May 2016, the impossible happened – Leicester won, to ecstatic celebrations in the city and around the world. Relive this remarkable season with Rob Tanner, the Leicester Mercury ’s chief football writer, from the great escape of 2015 to the curtain-closer at Stamford Bridge, via Ulloa’s last-gasp winner at Norwich and Vardy’s stunning volley against Liverpool. Detailing the key matches and turning points, Tanner’s book tells the inside story of Leicester City’s heroic year of triumph – and the players who under Claudio Ranieri’s inspired leadership became the most unlikely champions in football history.
Current Topics in Medical Mycology
Current Topics in Medical Mycology, which is a new annual series published by Springer-Verlag, is intended to summarize current topics in medical mycology for medical mycologists and other scientists who are work- ing in microbiology and immunology. Topics to be in- cluded in each year's volume will serve as contemporary reviews, summaries of current advancements and future directions, and mechanisms to enhance the interdiscipli- nary use of medically important fungi in the areas of pathogenesis, epidemiology, mycotoxins, taxonomy, and other areas where basic, applied, and clinical science are used. Michael R. McGinnis Contents ix Contributors 1 Pathology of the Mycoses in Patients with the ...
Red Rebels
In 2004, Manchester United could proclaim itself the richest football club in the world, and boasted global commercial appeal alongside more than a decade of success on the pitch. In early 2005, American businessman Malcolm Glazer targeted a leveraged takeover of the club, and it looked set to be plunged into record levels of debt. The fans were furious. If the deal went wrong, it would threaten United's very existence, whilst the Glazers would be able to walk away without it having cost them a cent. Protests in the stands fell on deaf ears – it became increasingly clear that marches and placards wouldn’t make any difference to the Glazer family. In May 2005 the takeover went ahead. In r...
Fungal Infections and Immune Responses
Biomedical scientists widely acknowledge that individuals' immune respon siveness is important in resistance to infections by microorganisms, including fungi. Because of the devastating acquired immunodeficiency syndrome (AIDS) epidemic, caused by the human immunodeficiency retrovirus, it is now accepted that suppressed immune responses, especially cellular immu nity, are important contributors to increased individual susceptibility to opportunistic infections-including infections caused by fungi which were at one time thought to be very lowly or nonpathogenic. Within the last few years, there has been an almost explosive increase in interest and studies concerning the nature and mechanisms of the immune response to fungal infections. Many immunologists who are not well versed in mycology have begun to study the nature and mechanisms of antifungal immunity using a wide variety of newer as well as more conventional immunologic technologies, both in vivo and in vitro. Up to the 1980s, however, there was little interest among basic immunologists concerning fungal immunity. This situation has changed dramatically in the past half decade, mainly because of AIDS.
Chemotherapy of Fungal Diseases
Fungal diseases have been with us from antiquity; interest in the chemo therapy of fungal disease has exploded in the past decade. To plan and pro duce a book on the topic of antifungal chemotherapy has come as a personal challenge - and something of an eye-opener - towards the end of my re search career. A landmark publication which still merits reading is Antifungal Chemotherapy (John Wiley & Sons, Chichester, UK), edited by David Speller, which appeared in 1980. However, the fact that ketoconazole, the first of the modern, orally active, wide-spectrum antifungals, attracted no more than two sentences in it indicates just how far we have come in the 1980s. A steady stream of original paper...
Clinical Mycology
Within the field of infectious diseases, medical mycology has experienced significant growth over the last decade. Invasive fungal infections have been increasing in many patient populations, including: those with AIDS; transplant recipients; and the elderly. As these populations grow, so does the diversity of fungal pathogens. Paralleling this development, there have been recent launches of several new antifungal drugs and therapies. Clinical Mycology offers a comprehensive review of this discipline. Organized by types of fungi, this volume covers microbiologic, epidemiologic and demographic aspects of fungal infections as well as diagnostic, clinical, therapeutic, and preventive approaches. Special patient populations are also detailed.
Antifungal Agents
This second volume of PDR SPECIAL TOPICS contains five review articles, covering nearly the entire field of fungal diseases in humans as well as therapeutic approaches. The main emphasis of the book lies in antifungal therapy: the most relevant information on the present state of the art of antifungal chemotherapy for dermatomycoses, subcutaneous and invasive mycoses is summarized, and open questions and unsolved problems are presented. The book is ideal for both the practitioner as well as advanced student.
